Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
Medroxyprogesterone Acetate Tablets USP
Medication labelWhy this: Advisory · dailymed-prescription
Medroxyprogesterone Acetate Tablets USP are a progestin indicated for the treatment of secondary amenorrhea and abnormal uterine bleeding due to hormonal imbalance in the absence of organic pathology, such as fibroids or uterine cancer. Medroxyprogesterone Acetate Tablets USP are also indicated to reduce the incidence of endometrial hyperplasia in nonhysterectomized postmenopausal women receiving daily oral conjugated estrogens 0.625 mg tablets.
- generic_name
- medroxyprogesterone acetate
- product_names
- Medroxyprogesterone Acetate
- ndc
- 33261-609, 0555-0872, 33261-609-30, 33261-740, 0555-0873, 33261-740-20, 33261-740-28, 33261-740-30, 33261-534, 0555-0779, 33261-534-05, 33261-534-10, 33261-534-14, 33261-534-30
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en